Recent Posts in Avandia Category
Posted on Nov 21, 2012 By Arnold & Itkin, LLP
GlaxoSmithKline (GSK) has agreed to pay $90 million to settle claims by 37 states and Washington D.C that the company illegally promoted its diabetes drug Avandia. The settlement resolves claims that ...
Continue reading "GSK Settles Avandia Claims for $90 Million" »
Posted on Sep 26, 2012 By Arnold & Itkin
Online shopping has taken over the world, seeing that just about any desired product can be purchased within the comforts of the home. There is no need to travel to the store, worry about busy parking ...
Continue reading "FDA Warning: Online Pharmacies Pose Potential Threat to Patients" »
Posted on Aug 17, 2012 By Arnold & Itkin LLP
A diabetes patient who sued drug manufacturer GlaxoSmithKline (GSK) over its diabetes drug Avandia has received the highest award ever recovered in an Israeli class-action suit against a drug ...
Continue reading "Avandia Settlement becomes Highest Ever Payout in Israel" »
Posted on Jul 10, 2012 By Arnold & Itkin LLP
Philadelphia drug manufacturer GlaxoSmithKline (GSK) has agreed to pay $3 billion to resolve allegations of fraud and failure to report safety data related to its business practices. The allegations ...
Continue reading "GSK Reaches Historical $3 Billion Dollar Settlement over Fraud Charges" »
Posted on Jun 23, 2012 By Houston Personal Injury Attorney
A new study published in the Archives of Internal Medicine reveals that the class of diabetes drugs known as thiazolidinediones (including Actos and Avandia) can increase the risk of patients ...
Continue reading "Diabetes Drugs Cause Vision Problems" »
Posted on Mar 7, 2012 By Pharmaceutical Injury Attorney
GlaxoSmithKline, the manufacturer of Avandia, recently issued a recall of near 400k bottles of their high blood pressure medication for fear of a possible mix-up at one of their manufacturing plants. ...
Continue reading "Mixup at GlaxoSmithKline Plants Leads to Recalls" »
Posted on Feb 2, 2012 By Pharmaceutical Injury Attorney
Recent news has surfaced in the controversial case surrounding the diabetes medication Avandia. GlaxoSmithKline, the company who marketed the medication, is paying $3 billion to resolve the whole ...
Continue reading "20,000 Avandia Lawsuits Settled" »